Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aventis-Pasteur Alters Fluzone Shipping Schedule To Ease Tight Supply

Executive Summary

Aventis-Pasteur is adjusting the shipping schedule for its flu vaccine Fluzone next season in an effort to help provide adequate flu vaccine supply.

You may also be interested in...



Aventis Fluzone shipments

Aventis-Pasteur will fill at least 25% of orders for its influenza vaccine Fluzone in September. Shipment began early in the month and all orders will be completed by November. Aventis decided to shift the shipping schedule to later in the year in order to encourage vaccination later in the season (1"The Pink Sheet" Feb. 19, p. 29)

Aventis Fluzone shipments

Aventis-Pasteur will fill at least 25% of orders for its influenza vaccine Fluzone in September. Shipment began early in the month and all orders will be completed by November. Aventis decided to shift the shipping schedule to later in the year in order to encourage vaccination later in the season (1"The Pink Sheet" Feb. 19, p. 29)

Flu Vaccine Distribution Guidance Needed For Suppliers, HIDA Says

The Centers for Disease Control & Prevention should provide guidance to vaccine distributors on prioritizing purchasers of influenza vaccine when there is a shortage, the Health Industry Distributors Association suggested in comments to the General Accounting Office.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037348

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel